Barclays
NRXS icon

Barclays’s Neuraxis NRXS Stock Holding History

Barclays’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95K Buy
+404
New +$2.98K ﹤0.01% 4831

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Barclays's NRXS Position: Q2 2026 in Review

Barclays opened a new position in Neuraxis (NRXS) in Q2 2026: 404 shares worth $2.95K. The stake represents ﹤0.01% of the portfolio and ranks #4831 among its holdings.

32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Barclays held 404 shares of Neuraxis worth $2.95K as of Q2 2026.
  • Neuraxis was a new Barclays position in Q2 2026.
  • Neuraxis made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4831 holding.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.